Cell and gene therapies are dominating the world of drug development. With the promise of significant breakthroughs to treat diabetes, cancer and congenital conditions, it is no wonder that research and development is predicted to reach $232.5 billion by 2026, up from $186 billion in 2019 according to Evaluate Pharma. Read the Full article at Manufacturing Chemist